Text automation business Data Grand has taken its total funding to more than $28.8m with a series B round that included Legend Holdings.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Wind turbine producer Goldwind returned and 36Kr Fund also invested as Tsinghua's rocket technology developer LandSpace secured $43.2m in a series B-plus round.

Wind turbine producer Goldwind returned and 36Kr Fund also invested as rocket technology developer LandSpace secured $43.2m in a series B-plus round.

Adidas, Samsung and WndrCo have taken part in PlayVS's $30.5m series B round, five months after the high school eSports league raised $15.5m.

Intel Capital and Airbus Ventures have both reinvested in the computer vision system developer, in a round that featured undisclosed auto component producers.

Novartis Venture Fund returned to reinvest in inflammatory disease drug developer Inflazome as part of its $45.6m series B round.

Inflammatory disease drug developer Inflazome, based on research at University of Queensland and Trinity College Dublin, has added $45.6m in series B capital to its coffers.

Novartis and Access Industries unit Clal Biotechnology Industries both took part in the neurological disorder drug developer's series B round.

Intel Capital led a series B round for the artificial intelligence-based processor developer, bringing its overall funding to $120m.